Trial record 1 of 1 for:
NCT03085095
A Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer (HERO)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03085095 |
Recruitment Status :
Recruiting
First Posted : March 21, 2017
Last Update Posted : October 29, 2020
|
Sponsor:
Myovant Sciences GmbH
Information provided by (Responsible Party):
Myovant Sciences GmbH
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Recruiting |
---|---|
Actual Primary Completion Date : | October 25, 2019 |
Estimated Study Completion Date : | November 1, 2021 |
Certification/Extension First Submitted : | October 5, 2020 |